{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,3]],"date-time":"2025-04-03T08:03:22Z","timestamp":1743667402300},"reference-count":41,"publisher":"American Association for Cancer Research (AACR)","issue":"23","content-domain":{"domain":["aacrjournals.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2007,12,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>DNA damage response (DDR) pathways maintain genomic stability. A 657del5 mutation of NBS1, a key DDR component, causing the rare cancer-predisposing Nijmegen breakage syndrome has been reported nearly exclusively in Slavic populations. In this study, we describe the first identification in a Japanese population of an unprecedented type of heterozygous NBS1 mutant, termed IVS11+2insT, lacking the MRE11- and ATM-binding site at the COOH terminus. Profoundly defective in crucial binding to MRE11, MDC1, BRCA1, and wild-type NBS1, the mutant caused impaired ATM phosphorylation in response to low-dose irradiation in a heterozygous state. Importantly, whereas IVS11+2insT was found in only 2 (0.09%) of 2,348 control subjects, it was identified in 2% (2 of 96) of heterozygotes with gastric cancer, 0.8% (3 of 376) of those with colorectal cancer, and 0.4% (2 of 532) of those with lung cancer, which were comparable to frequencies reported for other DDR-related genes known to confer cancer susceptibility. The presence of the heterozygous IVS11+2insT mutation seemed to be associated with an increased risk for gastrointestinal cancers, with an odds ratio of 12.6 and 95% confidence interval (95% CI) of 2.05 to 132.1 (P = 0.0001). The odds ratios separately calculated for gastric and colorectal cancers were 25.0 (95% CI, 1.78\u2013346.0) and 9.43 (95% CI, 1.08\u2013113.1), respectively. These findings suggest that IVS11+2insT is associated with an increased risk for the development of certain types of common cancers, warranting future investigation including detailed phenotypic characterization of age of onset and penetrance in heterozygotes, as well as screening in other ethnic groups. [Cancer Res 2007;67(23):11158\u201365]<\/jats:p>","DOI":"10.1158\/0008-5472.can-07-1749","type":"journal-article","created":{"date-parts":[[2007,12,3]],"date-time":"2007-12-03T19:23:27Z","timestamp":1196709807000},"page":"11158-11165","update-policy":"http:\/\/dx.doi.org\/10.1158\/crossmark_policy","source":"Crossref","is-referenced-by-count":26,"title":["Novel <i>NBS1<\/i> Heterozygous Germ Line Mutation Causing MRE11-Binding Domain Loss Predisposes to Common Types of Cancer"],"prefix":"10.1158","volume":"67","author":[{"given":"Hiromichi","family":"Ebi","sequence":"first","affiliation":[{"name":"1Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine;"},{"name":"2Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences; and Divisions of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keitaro","family":"Matsuo","sequence":"additional","affiliation":[{"name":"3Epidemiology and Prevention and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nobuyoshi","family":"Sugito","sequence":"additional","affiliation":[{"name":"1Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Motoshi","family":"Suzuki","sequence":"additional","affiliation":[{"name":"1Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hirotaka","family":"Osada","sequence":"additional","affiliation":[{"name":"4Molecular Oncology, Aichi Cancer Center Research Institute, Nagoya, Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazuo","family":"Tajima","sequence":"additional","affiliation":[{"name":"3Epidemiology and Prevention and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryuzo","family":"Ueda","sequence":"additional","affiliation":[{"name":"2Department of Internal Medicine and Molecular Science, Nagoya City University Graduate School of Medical Sciences; and Divisions of"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takashi","family":"Takahashi","sequence":"additional","affiliation":[{"name":"1Division of Molecular Carcinogenesis, Center for Neurological Diseases and Cancer, Nagoya University Graduate School of Medicine;"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1086","published-online":{"date-parts":[[2007,12,3]]},"reference":[{"key":"2022061623220607200_B1","doi-asserted-by":"crossref","unstructured":"Bartkova J, Horejsi Z, Koed K, et al. DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis. Nature\u20082005; 434: 864\u201370.","DOI":"10.1038\/nature03482"},{"key":"2022061623220607200_B2","doi-asserted-by":"crossref","unstructured":"Gorgoulis VG, Vassiliou LV, Karakaidos P, et al. Activation of the DNA damage checkpoint and genomic instability in human precancerous lesions. Nature\u20082005; 434: 907\u201313.","DOI":"10.1038\/nature03485"},{"key":"2022061623220607200_B3","unstructured":"Konishi H, Nakagawa T, Harano T, et al. Identification of frequent G(2) checkpoint impairment and a homozygous deletion of 14-3-3\u03b5 at 17p13.3 in small cell lung cancers. Cancer Res\u20082002; 62: 271\u20136."},{"key":"2022061623220607200_B4","doi-asserted-by":"crossref","unstructured":"Takahashi T, Haruki N, Nomoto S, et al. Identification of frequent impairment of the mitotic checkpoint and molecular analysis of the mitotic checkpoint genes, hsMAD2 and p55CDC, in human lung cancers. Oncogene\u20081999; 18: 4295\u2013300.","DOI":"10.1038\/sj.onc.1202807"},{"key":"2022061623220607200_B5","doi-asserted-by":"crossref","unstructured":"Nakagawa T, Hayashita Y, Maeno K, et al. Identification of decatenation G2 checkpoint impairment independently of DNA damage G2 checkpoint in human lung cancer cell lines. Cancer Res\u20082004; 64: 4826\u201332.","DOI":"10.1158\/0008-5472.CAN-04-0871"},{"key":"2022061623220607200_B6","doi-asserted-by":"crossref","unstructured":"Digweed M, Sperling K. Nijmegen breakage syndrome: clinical manifestation of defective response to DNA double-strand breaks. DNA Repair (Amst)\u20082004; 3: 1207\u201317.","DOI":"10.1016\/j.dnarep.2004.03.004"},{"key":"2022061623220607200_B7","doi-asserted-by":"crossref","unstructured":"Varon R, Vissinga C, Platzer M, et al. Nibrin, a novel DNA double-strand break repair protein, is mutated in Nijmegen breakage syndrome. Cell\u20081998; 93: 467\u201376.","DOI":"10.1016\/S0092-8674(00)81174-5"},{"key":"2022061623220607200_B8","doi-asserted-by":"crossref","unstructured":"Maser RS, Zinkel R, Petrini JH. An alternative mode of translation permits production of a variant NBS1 protein from the common Nijmegen breakage syndrome allele. Nat Genet\u20082001; 27: 417\u201321.","DOI":"10.1038\/86920"},{"key":"2022061623220607200_B9","doi-asserted-by":"crossref","unstructured":"Inoue M, Tajima K, Hirose K, et al. Epidemiological features of first-visit outpatients in Japan: comparison with general population and variation by sex, age, and season. J Clin Epidemiol\u20081997; 50: 69\u201377.","DOI":"10.1016\/S0895-4356(96)00297-1"},{"key":"2022061623220607200_B10","doi-asserted-by":"crossref","unstructured":"Yoshimura K, Hanaoka T, Ohnami S, et al. Allele frequencies of single nucleotide polymorphisms (SNPs) in 40 candidate genes for gene-environment studies on cancer: data from population-based Japanese random samples. J Hum Genet\u20082003; 48: 654\u20138.","DOI":"10.1007\/s10038-003-0096-1"},{"key":"2022061623220607200_B11","doi-asserted-by":"crossref","unstructured":"Matsuo K, Wakai K, Hirose K, et al. Alcohol dehydrogenase 2 His47Arg polymorphism influences drinking habit independently of aldehyde dehydrogenase 2 Glu487Lys polymorphism: analysis of 2,299 Japanese subjects. Cancer Epidemiol Biomarkers Prev\u20082006; 15: 1009\u201313.","DOI":"10.1158\/1055-9965.EPI-05-0911"},{"key":"2022061623220607200_B12","doi-asserted-by":"crossref","unstructured":"Matsuo K, Ito H, Yatabe Y, et al. Risk factors differ for non-small-cell lung cancers with and without EGFR mutation: assessment of smoking and sex by a case-control study in Japanese. Cancer Sci\u20082007; 98: 96\u2013101.","DOI":"10.1111\/j.1349-7006.2006.00347.x"},{"key":"2022061623220607200_B13","doi-asserted-by":"crossref","unstructured":"Inoue M, Tajima K, Hirose K, et al. Subsite-specific risk factors for colorectal cancer: a hospital-based case-control study in Japan. Cancer Causes Control\u20081995; 6: 14\u201322.","DOI":"10.1007\/BF00051676"},{"key":"2022061623220607200_B14","doi-asserted-by":"crossref","unstructured":"Falck J, Petrini JH, Williams BR, Lukas J, Bartek J. The DNA damage-dependent intra-S phase checkpoint is regulated by parallel pathways. Nat Genet\u20082002; 30: 290\u20134.","DOI":"10.1038\/ng845"},{"key":"2022061623220607200_B15","unstructured":"Wu W, Fan YH, Kemp BL, Walsh G, Mao L. Overexpression of cdc25A and cdc25B is frequent in primary non-small cell lung cancer but is not associated with overexpression of c-myc. Cancer Res\u20081998; 58: 4082\u20135."},{"key":"2022061623220607200_B16","doi-asserted-by":"crossref","unstructured":"Falck J, Coates J, Jackson SP. Conserved modes of recruitment of ATM, ATR and DNA-PKcs to sites of DNA damage. Nature\u20082005; 434: 605\u201311.","DOI":"10.1038\/nature03442"},{"key":"2022061623220607200_B17","doi-asserted-by":"crossref","unstructured":"Dupre A, Boyer-Chatenet L, Gautier J. Two-step activation of ATM by DNA and the Mre11-50-Nbs1 complex. Nat Struct Mol Biol\u20082006; 13: 451\u20137.","DOI":"10.1038\/nsmb1090"},{"key":"2022061623220607200_B18","doi-asserted-by":"crossref","unstructured":"Uziel T, Lerenthal Y, Moyal L, et al. Requirement of the MRN complex for ATM activation by DNA damage. EMBO J\u20082003; 22: 5612\u201321.","DOI":"10.1093\/emboj\/cdg541"},{"key":"2022061623220607200_B19","doi-asserted-by":"crossref","unstructured":"Zhong Q, Chen CF, Li S, et al. Association of BRCA1 with the hRad50\u201311-p95 complex and the DNA damage response. Science\u20081999; 285: 747\u201350.","DOI":"10.1126\/science.285.5428.747"},{"key":"2022061623220607200_B20","doi-asserted-by":"crossref","unstructured":"Kobayashi J, Tauchi H, Sakamoto S, et al. NBS1 localizes to \u03b3-H2AX foci through interaction with the FHA\/BRCT domain. Curr Biol\u20082002; 12: 1846\u201351.","DOI":"10.1016\/S0960-9822(02)01259-9"},{"key":"2022061623220607200_B21","doi-asserted-by":"crossref","unstructured":"Lukas C, Melander F, Stucki M, et al. Mdc1 couples DNA double-strand break recognition by Nbs1 with its H2AX-dependent chromatin retention. EMBO J\u20082004; 23: 2674\u201383.","DOI":"10.1038\/sj.emboj.7600269"},{"key":"2022061623220607200_B22","doi-asserted-by":"crossref","unstructured":"Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature\u20082003; 421: 499\u2013506.","DOI":"10.1038\/nature01368"},{"key":"2022061623220607200_B23","doi-asserted-by":"crossref","unstructured":"Difilippantonio S, Celeste A, Fernandez-Capetillo O, et al. Role of Nbs1 in the activation of the Atm kinase revealed in humanized mouse models. Nat Cell Biol\u20082005; 7: 675\u201385.","DOI":"10.1038\/ncb1270"},{"key":"2022061623220607200_B24","doi-asserted-by":"crossref","unstructured":"Steffen J, Varon R, Mosor M, et al. Increased cancer risk of heterozygotes with NBS1 germline mutations in Poland. Int J Cancer\u20082004; 111: 67\u201371.","DOI":"10.1002\/ijc.20239"},{"key":"2022061623220607200_B25","doi-asserted-by":"crossref","unstructured":"Cybulski C, Gorski B, Debniak T, et al. NBS1 is a prostate cancer susceptibility gene. Cancer Res\u20082004; 64: 1215\u20139.","DOI":"10.1158\/0008-5472.CAN-03-2502"},{"key":"2022061623220607200_B26","doi-asserted-by":"crossref","unstructured":"Shimada H, Shimizu K, Mimaki S, et al. First case of aplastic anemia in a Japanese child with a homozygous missense mutation in the NBS1 gene (I171V) associated with genomic instability. Hum Genet\u20082004; 115: 372\u20136.","DOI":"10.1007\/s00439-004-1155-1"},{"key":"2022061623220607200_B27","doi-asserted-by":"crossref","unstructured":"Gottlieb E, Haffner R, King A, et al. Transgenic mouse model for studying the transcriptional activity of the p53 protein: age- and tissue-dependent changes in radiation-induced activation during embryogenesis. EMBO J\u20081997; 16: 1381\u201390.","DOI":"10.1093\/emboj\/16.6.1381"},{"key":"2022061623220607200_B28","doi-asserted-by":"crossref","unstructured":"Dai W, Wang Q, Liu T, et al. Slippage of mitotic arrest and enhanced tumor development in mice with BubR1 haploinsufficiency. Cancer Res\u20082004; 64: 440\u20135.","DOI":"10.1158\/0008-5472.CAN-03-3119"},{"key":"2022061623220607200_B29","doi-asserted-by":"crossref","unstructured":"Barlow C, Eckhaus MA, Schaffer AA, Wynshaw-Boris A. Atm haploinsufficiency results in increased sensitivity to sublethal doses of ionizing radiation in mice. Nat Genet\u20081999; 21: 359\u201360.","DOI":"10.1038\/7684"},{"key":"2022061623220607200_B30","doi-asserted-by":"crossref","unstructured":"Reina-San-Martin B, Nussenzweig MC, Nussenzweig A, Difilippantonio S. Genomic instability, endoreduplication, and diminished Ig class-switch recombination in B cells lacking Nbs1. Proc Natl Acad Sci U S A\u20082005; 102: 1590\u20135.","DOI":"10.1073\/pnas.0406289102"},{"key":"2022061623220607200_B31","unstructured":"Dumon-Jones V, Frappart PO, Tong WM, et al. Nbn heterozygosity renders mice susceptible to tumor formation and ionizing radiation-induced tumorigenesis. Cancer Res\u20082003; 63: 7263\u20139."},{"key":"2022061623220607200_B32","doi-asserted-by":"crossref","unstructured":"Kastan MB, Bartek J. Cell-cycle checkpoints and cancer. Nature\u20082004; 432: 316\u201323.","DOI":"10.1038\/nature03097"},{"key":"2022061623220607200_B33","doi-asserted-by":"crossref","unstructured":"Gruber SB, Ellis NA, Scott KK, et al. BLM heterozygosity and the risk of colorectal cancer. Science\u20082002; 297: 2013.","DOI":"10.1126\/science.1074399"},{"key":"2022061623220607200_B34","doi-asserted-by":"crossref","unstructured":"Thompson D, Duedal S, Kirner J, et al. Cancer risks and mortality in heterozygous ATM mutation carriers. J Natl Cancer Inst\u20082005; 97: 813\u201322.","DOI":"10.1093\/jnci\/dji141"},{"key":"2022061623220607200_B35","doi-asserted-by":"crossref","unstructured":"Olsen JH, Hahnemann JM, Borresen-Dale AL, et al. Cancer in patients with ataxia-telangiectasia and in their relatives in the nordic countries. J Natl Cancer Inst\u20082001; 93: 121\u20137.","DOI":"10.1093\/jnci\/93.2.121"},{"key":"2022061623220607200_B36","doi-asserted-by":"crossref","unstructured":"Meijers-Heijboer H, Wijnen J, Vasen H, et al. The CHEK2 1100delC mutation identifies families with a hereditary breast and colorectal cancer phenotype. Am J Hum Genet\u20082003; 72: 1308\u201314.","DOI":"10.1086\/375121"},{"key":"2022061623220607200_B37","doi-asserted-by":"crossref","unstructured":"Guilford P, Hopkins J, Harraway J, et al. E-Cadherin germline mutations in familial gastric cancer. Nature\u20081998; 392: 402\u20135.","DOI":"10.1038\/32918"},{"key":"2022061623220607200_B38","unstructured":"Iida S, Akiyama Y, Ichikawa W, et al. Infrequent germ-line mutation of the E-cadherin gene in Japanese familial gastric cancer kindreds. Clin Cancer Res\u20081999; 5: 1445\u20137."},{"key":"2022061623220607200_B39","doi-asserted-by":"crossref","unstructured":"Ajiki W, Tsukuma H, Oshima A. Cancer incidence and incidence rates in Japan in 1999: estimates based on data from 11 population-based cancer registries. Jpn J Clin Oncol\u20082004; 34: 352\u20136.","DOI":"10.1093\/jjco\/hyh056"},{"key":"2022061623220607200_B40","doi-asserted-by":"crossref","unstructured":"Sellers TA, Bailey-Wilson JE, Elston RC, et al. Evidence for mendelian inheritance in the pathogenesis of lung cancer. J Natl Cancer Inst\u20081990; 82: 1272\u20139.","DOI":"10.1093\/jnci\/82.15.1272"},{"key":"2022061623220607200_B41","doi-asserted-by":"crossref","unstructured":"Yang P, Schwartz AG, McAllister AE, Swanson GM, Aston CE. Lung cancer risk in families of nonsmoking probands: heterogeneity by age at diagnosis. Genet Epidemiol\u20081999; 17: 253\u201373.","DOI":"10.1002\/(SICI)1098-2272(199911)17:4<253::AID-GEPI2>3.0.CO;2-K"}],"container-title":["Cancer Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/23\/11158\/2575506\/11158.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/aacrjournals.org\/cancerres\/article-pdf\/67\/23\/11158\/2575506\/11158.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T03:01:27Z","timestamp":1655434887000},"score":1,"resource":{"primary":{"URL":"https:\/\/aacrjournals.org\/cancerres\/article\/67\/23\/11158\/533726\/Novel-NBS1-Heterozygous-Germ-Line-Mutation-Causing"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,12,1]]},"references-count":41,"journal-issue":{"issue":"23","published-online":{"date-parts":[[2007,12,3]]},"published-print":{"date-parts":[[2007,12,1]]}},"URL":"https:\/\/doi.org\/10.1158\/0008-5472.can-07-1749","relation":{},"ISSN":["0008-5472","1538-7445"],"issn-type":[{"value":"0008-5472","type":"print"},{"value":"1538-7445","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,12,1]]}}}